NeoGenomics
332 hedge funds and large institutions have $5.21B invested in NeoGenomics in 2021 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 116 increasing their positions, 121 reducing their positions, and 47 closing their positions.
330% more call options, than puts
Call options by funds: $29.1M | Put options by funds: $6.76M
4% less repeat investments, than reductions
Existing positions increased: 116 | Existing positions reduced: 121
1.23% less ownership
Funds ownership: 93.6% → 92.37% (-1.2%)
2% less funds holding
Funds holding: 340 → 332 (-8)
7% less capital invested
Capital invested by funds: $5.59B → $5.21B (-$386M)
11% less first-time investments, than exits
New positions opened: 42 | Existing positions closed: 47
17% less funds holding in top 10
Funds holding in top 10: 12 → 10 (-2)
Top Buyers
| 1 |
BlackRock
New York
|
+$77.8M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$72.2M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$46.5M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$44.8M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$28M |
Top Sellers
| 1 |
KFO
Kopp Family Office
Bloomington,
Minnesota
|
-$45.6M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$33.2M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$29.6M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$14.3M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$8.77M |
NEO Hedge Fund Activity: Q1 2021 in Review
332 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q1 2021, worth a combined $5.21B — down 6.9% from $5.59B a quarter earlier.
Sellers outnumbered buyers: 47 funds closed out of NEO and 42 opened new positions — a net loss of 5 holders — while 121 trimmed existing stakes and 116 added.
The largest buyer was BlackRock, adding an estimated $77.8M. The largest seller was Kopp Family Office, cutting an estimated $45.6M.
- 332 institutional investors held NeoGenomics (NEO) as of Q1 2021, down from 340 in Q4 2020.
- Funds reported $5.21B of NeoGenomics stock for Q1 2021, down 6.9% quarter-over-quarter.
- 42 funds opened new NeoGenomics positions in Q1 2021 and 47 closed out, a net change of -5 holders.
- The largest NeoGenomics buyer in Q1 2021 was BlackRock, an estimated $77.8M added.
- The largest NeoGenomics seller in Q1 2021 was Kopp Family Office, an estimated $45.6M sold.
Based on aggregated 13F filings for Q1 2021.